Literature DB >> 11104650

Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion.

Y Yamaguchi1, H Ohshiro, Y Nagao, K Odawara, K Okabe, H Hidaka, K Ishihara, S Uchino, T Furuhashi, S Yamada, K Mori, M Ogawa.   

Abstract

BACKGROUND AND AIM: Protease inhibitors attenuate ischemia/reperfusion injury. However, the underlying mechanisms by which protease inhibitors prevent reperfusion injury remain obscure. Neutrophils play an important role in reperfusion injury. We studied the effects of urinary trypsin inhibitor (UTI) on production of the C-X-C chemokine, cytokine-induced neutrophil chemoattractant (CINC), by Kupffer cells during ischemia/reperfusion of the liver.
METHODS: Liver ischemia was induced in rats by occlusion of the portal vein for 30 min. UTI (50,000 U/kg) was injected intravenously 5 min before vascular clamping. Serum CINC concentrations were measured by enzyme-linked immunosorbent assay. Levels of CINC mRNA in the liver were determined by Northern blot analysis. We also examined the inhibitory effects of UTI on in vitro CINC production by peritoneal macrophages in response to neutrophil elastase (NE).
RESULTS: Serum CINC concentrations increased and peaked 6 h after reperfusion. However, pretreatment of animals with UTI blunted this increase in CINC and significantly reduced CINC mRNA levels in the liver after ischemia/reperfusion. UTI also decreased neutrophil accumulation in the liver 24 h after reperfusion. In vitro CINC production by Kupffer cells from rats pretreated with UTI 3 h after ischemia/reperfusion was significantly decreased compared to those from untreated animals. UTI reduced NE activity in vitro in a dose-dependent manner, and UTI significantly reduced in vitro CINC production by peritoneal macrophages stimulated with NE.
CONCLUSION: UTI reduces the production of CINC by Kupffer cells stimulated with NE, attenuating ischemia/reperfusion injury of the liver. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104650     DOI: 10.1006/jsre.2000.5999

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.

Authors:  Tomoki Nishiyama; Takeshi Yokoyama; Koichi Yamashita
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

3.  Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation.

Authors:  Ji-Ren Yu; Sheng Yan; Xiao-Sun Liu; Yi-Jun Wu; Pei-Feng Fu; Li-Hua Wu; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Ulinastatin inhibits cerebral ischemia-induced apoptosis in the hippocampus of gerbils.

Authors:  Young-Sam Cho; Mal-Soon Shin; Il-Gyu Ko; Sung-Eun Kim; Chang-Ju Kim; Yun-Hee Sung; Hye-Sun Yoon; Bong-Jae Lee
Journal:  Mol Med Rep       Date:  2015-04-15       Impact factor: 2.952

5.  Urinary Trypsin Inhibitor Ameliorates Seawater Immersion-Induced Intestinal Mucosa Injury via Antioxidation, Modulation of NF-κB Activity, and Its Related Cytokines in Rats with Open Abdominal Injury.

Authors:  Xing Jian Zhang; Ya Li Wang; Song Zhou; Xiaojun Xue; Qiang Liu; Wen Hua Zhang; Jun Zheng
Journal:  Gastroenterol Res Pract       Date:  2014-08-21       Impact factor: 2.260

6.  The Protective Roles of Urinary Trypsin Inhibitor in Brain Injury Following Fat Embolism Syndrome in a Rat Model.

Authors:  Lili Xiong; Linlin Sun; Shanshan Liu; Xingyun Zhu; Ze Teng; Junhao Yan
Journal:  Cell Transplant       Date:  2018-11-19       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.